🇮🇳IN
Sign In
VI

VISTAPH

BSE

Vista Pharmaceuticals Ltd

₹6.47

+0.30(+4.86%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

VISTAPH valuation summary

Return on equity is -29.5% and return on capital employed is -30.3%.

ROE-29.5%
ROCE-30.3%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer